Genomictree Inc. (228760) — Financial Flexibility Index
Genomictree Inc. (228760) has a Financial Flexibility Index of -0.58x as of December 2025. Free cash flow of ₩-3.15 Billion (operating CF ₩-3.21 Billion minus capex ₩62.29 Million) represents -1% of total liabilities (₩5.45 Billion). Check Genomictree Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Genomictree Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Genomictree Inc. across 6 annual periods. For the full cash flow conversion analysis, see 228760 cash generation efficiency.
Annual Financial Flexibility Index for Genomictree Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Genomictree Inc.. Explore 228760 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.37x | ₩-7.45 Billion | ₩-10.19 Billion | ₩5.45 Billion | ▲ +21.7% |
| 2024 | -1.74x | ₩-11.08 Billion | ₩-13.63 Billion | ₩6.36 Billion | ▼ -28.6% |
| 2023 | -1.36x | ₩-10.59 Billion | ₩-10.88 Billion | ₩7.81 Billion | ▼ -1339.5% |
| 2022 | 0.11x | ₩6.11 Billion | ₩4.29 Billion | ₩55.86 Billion | ▲ +61.7% |
| 2021 | 0.07x | ₩4.20 Billion | ₩-7.63 Billion | ₩62.05 Billion | ▲ +120.4% |
| 2020 | -0.33x | ₩-7.50 Billion | ₩-10.19 Billion | ₩22.64 Billion | — |